EverSource Wealth Advisors’s Regenxbio RGNX Stock Holding History

EverSource Wealth Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.13K	Sell	595 -1,234	-67%	-$10.2K	﹤0.01%	3106
2026 Q1	$15.3K	Sell	1,829 -676	-27%	-$7.1K	﹤0.01%	2666
2025 Q4	$36.1K	Buy	2,505 +534	+27%	+$6.66K	﹤0.01%	1979
2025 Q3	$19K	Buy	1,971 +694	+54%	+$6.14K	﹤0.01%	2395
2025 Q2	$10.5K	Buy	1,277 +983	+334%	+$8.23K	﹤0.01%	2776
2025 Q1	$2.1K	Buy	294 +282	+2,350%	+$2.1K	﹤0.01%	2905
2024 Q4	$93	Buy	+12	New	+$113	﹤0.01%	3559
2022 Q2	–	Sell	-70	Closed	-$2K	–	1860
2022 Q1	$2K	Buy	+70	New	+$1.94K	﹤0.01%	1568

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

EverSource Wealth Advisors's RGNX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Regenxbio (RGNX) stake by 67% in Q2 2026, selling an estimated $10.2K and leaving 595 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

EverSource Wealth Advisors first reported a position in RGNX in Q1 2022 and has held it in 8 quarters since. The position peaked at $36.1K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

EverSource Wealth Advisors held 595 shares of Regenxbio worth $7.13K as of Q2 2026.
EverSource Wealth Advisors sold 1,234 Regenxbio shares in Q2 2026, an estimated $10.2K.
Regenxbio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3106 holding.
EverSource Wealth Advisors first reported a position in Regenxbio in Q1 2022 and has held it in 8 quarters since.
EverSource Wealth Advisors's Regenxbio position peaked at $36.1K in Q4 2025.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.